Search
Returning search results with filters:
Remove filter for
Audience: Retail
Remove filter for
Category: Health products
Remove filter for
Recall class: Type II
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 7 of 7 items.
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list. Test results for Lot 20220331 found the product to contain bimatoprost.…
RecallHealth product recall | 2022-09-26
Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406.
RecallHealth product recall | 2022-09-22
Out of Specification result for Finished Product Assay and/or Blend Uniformity
RecallHealth product recall | 2022-09-21
Out of specification result for Spheroids Dissolution Rate Profile (DRP)
RecallHealth product recall | 2022-09-21
The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
RecallHealth product recall | 2022-09-02
The dissolution for vitamin D3 is out of specification in the affected lots.
RecallHealth product recall | 2022-08-22
These products are being recalled because of a potential leak due to a weak seam at the upper middle seam near the nose wire. Not all of the products are affected, but to ERR on the side of caution all masks that were produced between…
RecallHealth product recall | 2021-11-26